申请人:Schering Corporation
公开号:US05654316A1
公开(公告)日:1997-08-05
The invention relates to compounds of the formula ##STR1## wherein X, i, j, n, n', A, A', R.sub.2, R.sub.3, and U are as described herein. The compounds of the invention are NK.sub.1 or NK.sub.2 or NK.sub.3 receptor antagonists and as such are useful in the treatment of diseases such as asthma.
本发明涉及以下公式的化合物:##STR1## 其中X、i、j、n、n'、A、A'、R.sub.2、R.sub.3和U如本文所述。本发明的化合物是NK.sub.1或NK.sub.2或NK.sub.3受体拮抗剂,因此在哮喘等疾病的治疗中有用。